SA, P., J, K., LH, D., & G, T. (2026). Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis? Diabetes, obesity & metabolism, 28(4), 2507. https://doi.org/10.1111/dom.70507
Chicago Style (17th ed.) CitationSA, Polyzos, Kountouras J, Duntas LH, and Targher G. "Is the Combination of Resmetirom and Semaglutide Useful for the Treatment of Metabolic Dysfunction-associated Steatohepatitis?" Diabetes, Obesity & Metabolism 28, no. 4 (2026): 2507. https://doi.org/10.1111/dom.70507.
MLA (9th ed.) CitationSA, Polyzos, et al. "Is the Combination of Resmetirom and Semaglutide Useful for the Treatment of Metabolic Dysfunction-associated Steatohepatitis?" Diabetes, Obesity & Metabolism, vol. 28, no. 4, 2026, p. 2507, https://doi.org/10.1111/dom.70507.